PriceTargets.com logo

NASDAQ:RPD - Rapid7 Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $138.53
  • Forecasted Upside: 43.63 %
  • Number of Analysts: 15
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 14 Buy Ratings
  • 0 Strong Buy Ratings
$96.45 As of 01/14/2022 01:00 AM ET
▼ -1.11 (-1.14%)

This chart shows the closing price for RPD by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Rapid7 Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for RPD and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for RPD

Analyst Price Target is $138.53
▲ +43.63% Upside Potential
This price target is based on 15 analysts offering 12 month price targets for Rapid7 in the last 3 months. The average price target is $138.53, with a high forecast of $162.00 and a low forecast of $100.00. The average price target represents a 43.63% upside from the last price of $96.45.

This chart shows the closing price for RPD for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 15 contributing investment analysts is to buy stock in Rapid7. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 11 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
7/26/2020
  • 0 strong buy ratings
  • 11 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
10/24/2020
  • 0 strong buy ratings
  • 10 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
1/22/2021
  • 0 strong buy ratings
  • 9 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
4/22/2021
  • 0 strong buy ratings
  • 11 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
7/21/2021
  • 0 strong buy ratings
  • 14 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
10/19/2021
  • 0 strong buy ratings
  • 14 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
12/18/2021
  • 0 strong buy ratings
  • 14 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
1/17/2022

Latest Recommendations

  • 0 strong buy ratings
  • 14 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
12/3/2021MizuhoReiterated RatingBuy$154.00N/A
11/4/2021Morgan StanleyBoost Price TargetEqual Weight$97.00 ➝ $106.00High
11/4/2021Stifel NicolausBoost Price TargetBuy$140.00 ➝ $160.00High
11/4/2021MizuhoBoost Price TargetBuy$138.00 ➝ $155.00High
11/4/2021Needham & Company LLCBoost Price TargetBuy$140.00 ➝ $155.00High
11/4/2021Raymond JamesBoost Price TargetOutperform$130.00 ➝ $145.00High
11/4/2021BarclaysBoost Price TargetOverweight$130.00 ➝ $141.00Medium
11/4/2021KeyCorpBoost Price TargetOverweight$141.00 ➝ $162.00Medium
11/4/2021Piper SandlerBoost Price TargetOverweight$130.00 ➝ $145.00Medium
11/1/2021Royal Bank of CanadaBoost Price TargetPositive ➝ Outperform$138.00 ➝ $150.00High
10/18/2021MizuhoBoost Price TargetBuy$125.00 ➝ $138.00High
9/23/2021FBN SecuritiesInitiated CoverageOutperform$140.00Medium
9/13/2021The Goldman Sachs GroupBoost Price TargetBuy$130.00 ➝ $140.00Low
8/6/2021The Goldman Sachs GroupBoost Price TargetBuy$114.00 ➝ $130.00Low
8/5/2021Truist SecuritiesBoost Price TargetBuy$110.00 ➝ $125.00Low
8/5/2021TruistBoost Price TargetBuy$110.00 ➝ $125.00Medium
8/5/2021Morgan StanleyBoost Price TargetEqual Weight$94.00 ➝ $97.00Low
8/5/2021Needham & Company LLCBoost Price TargetPositive ➝ Buy$130.00 ➝ $140.00High
8/5/2021Raymond JamesBoost Price TargetOutperform$105.00 ➝ $130.00High
8/5/2021Royal Bank of CanadaBoost Price TargetOutperform$120.00 ➝ $138.00High
8/5/2021Robert W. BairdBoost Price TargetOutperform$95.00 ➝ $130.00High
8/5/2021BarclaysBoost Price TargetOverweight$115.00 ➝ $130.00High
8/5/2021MizuhoBoost Price TargetBuy$110.00 ➝ $125.00High
8/2/2021KeyCorpInitiated CoverageOverweight$135.00Medium
7/20/2021Needham & Company LLCInitiated CoverageBuy$130.00High
7/20/2021TruistBoost Price TargetPositive ➝ Buy$95.00 ➝ $110.00High
7/20/2021Royal Bank of CanadaBoost Price TargetPositive ➝ Outperform$110.00 ➝ $120.00High
7/20/2021Truist SecuritiesBoost Price TargetBuy$95.00 ➝ $110.00High
7/16/2021MizuhoBoost Price TargetHold ➝ Buy$92.00 ➝ $110.00Low
7/15/2021BarclaysBoost Price TargetOverweight$104.00 ➝ $115.00Medium
7/14/2021Needham & Company LLCBoost Price TargetBuy$110.00 ➝ $130.00Low
7/9/2021Piper SandlerBoost Price TargetOverweight$100.00 ➝ $110.00Medium
5/7/2021Raymond JamesBoost Price TargetOutperform$100.00 ➝ $105.00High
5/7/2021MizuhoLower Price TargetBuy$102.00 ➝ $92.00Low
3/8/2021Piper SandlerUpgradeNeutral ➝ Overweight$100.00N/A
3/2/2021Piper SandlerUpgradeNeutral ➝ Overweight$95.00 ➝ $100.00Low
2/17/2021Stifel NicolausInitiated CoverageBuyHigh
2/10/2021Morgan StanleyBoost Price TargetEqual Weight$86.00 ➝ $94.00Low
2/10/2021Needham & Company LLCBoost Price TargetBuy$82.00 ➝ $110.00Low
2/10/2021Raymond JamesBoost Price TargetOutperform$72.00 ➝ $100.00Low
2/10/2021Royal Bank of CanadaBoost Price TargetOutperform$105.00 ➝ $110.00Low
1/27/2021TruistBoost Price Target$72.00 ➝ $95.00High
1/22/2021Royal Bank of CanadaBoost Price TargetPositive ➝ Outperform$77.00 ➝ $105.00Medium
1/19/2021Monness Crespi & HardtBoost Price TargetBuy$77.00 ➝ $100.00High
1/12/2021MizuhoBoost Price TargetBuy$80.00 ➝ $102.00Low
1/8/2021Morgan StanleyBoost Price TargetEqual Weight$71.00 ➝ $86.00Low
1/6/2021BarclaysBoost Price TargetOverweight$77.00 ➝ $101.00N/A
1/4/2021Piper SandlerDowngradeOverweight ➝ Neutral$95.00N/A
11/5/2020Royal Bank of CanadaBoost Price TargetOutperform$70.00 ➝ $77.00High
11/5/2020Raymond JamesBoost Price TargetOutperform$70.00 ➝ $72.00High
11/5/2020Morgan StanleyBoost Price TargetEqual Weight$60.00 ➝ $61.00High
11/5/2020Needham & Company LLCBoost Price TargetBuy$72.00 ➝ $82.00High
11/5/2020Monness Crespi & HardtBoost Price TargetBuy$70.00 ➝ $77.00High
11/5/2020MizuhoBoost Price TargetBuy$75.00 ➝ $80.00High
11/5/2020BarclaysBoost Price TargetOverweight$70.00 ➝ $77.00High
10/15/2020MizuhoBoost Price TargetBuy$70.00 ➝ $75.00Medium
9/9/2020Morgan StanleyBoost Price TargetEqual Weight$55.00 ➝ $60.00Low
8/7/2020Needham & Company LLCReiterated RatingBuy$72.00Medium
8/7/2020Monness Crespi & HardtBoost Price TargetBuy$60.00 ➝ $70.00High
8/7/2020Raymond JamesBoost Price TargetStrong-Buy$64.00 ➝ $70.00High
8/7/2020MizuhoBoost Price TargetBuy$60.00 ➝ $70.00High
8/7/2020Piper SandlerBoost Price TargetOverweight$60.00 ➝ $75.00High
8/7/2020Robert W. BairdReiterated RatingBuyHigh
7/20/2020BarclaysBoost Price TargetOverweight$58.00 ➝ $65.00High
5/13/2020Morgan StanleyBoost Price TargetEqual Weight$43.00 ➝ $50.00Medium
5/10/2020Royal Bank of CanadaReiterated RatingBuy$65.00Medium
5/8/2020Raymond JamesBoost Price TargetStrong-Buy$53.00 ➝ $64.00Medium
5/8/2020MizuhoBoost Price TargetBuy$50.00 ➝ $53.00High
5/8/2020Robert W. BairdReiterated RatingBuyMedium
5/4/2020BarclaysLower Price TargetOverweight$51.00 ➝ $49.00Medium
4/30/2020MizuhoLower Price TargetBuy$52.00 ➝ $50.00Low
4/29/2020Monness Crespi & HardtLower Price TargetBuy$72.00 ➝ $60.00High
4/21/2020CowenLower Price TargetOutperform$70.00 ➝ $55.00Low
4/3/2020Raymond JamesLower Price TargetStrong-Buy$72.00 ➝ $53.00High
3/25/2020Morgan StanleyLower Price TargetEqual Weight$60.00 ➝ $43.00Medium
3/24/2020The Goldman Sachs GroupInitiated CoverageBuy$49.00Medium
3/18/2020Royal Bank of CanadaReiterated RatingBuy$65.00Medium
2/11/2020MizuhoReiterated RatingBuy$68.00Medium
2/11/2020Raymond JamesLower Price TargetStrong-Buy$75.00 ➝ $72.00High
2/11/2020Robert W. BairdReiterated RatingBuy$72.00High
1/22/2020Raymond JamesBoost Price TargetStrong-Buy$69.00 ➝ $75.00Low
12/9/2019Piper Jaffray CompaniesInitiated CoverageOverweight$67.00Low
11/5/2019Needham & Company LLCReiterated RatingBuy$72.00High
11/5/2019Robert W. BairdReiterated RatingBuy$72.00High
10/8/2019Robert W. BairdSet Price TargetBuy$72.00Low
10/2/2019SunTrust BanksInitiated CoverageBuy$66.00High
9/15/2019Robert W. BairdSet Price TargetBuy$72.00Medium
8/2/2019Morgan StanleyBoost Price TargetEqual Weight$51.00 ➝ $61.00Low
7/29/2019Needham & Company LLCBoost Price TargetBuy$60.00 ➝ $72.00High
7/29/2019Royal Bank of CanadaBoost Price TargetPositive ➝ Outperform$70.00High
7/29/2019Monness Crespi & HardtReiterated RatingBuy ➝ Buy$62.00 ➝ $72.00High
7/18/2019BarclaysReiterated RatingBuy$69.00Low
7/15/2019Northland SecuritiesSet Price TargetBuy$75.00Low
6/28/2019Nomura SecuritiesInitiated CoverageBuy ➝ Buy$70.00 ➝ $70.00High
5/23/2019CowenInitiated CoverageOutperform ➝ Outperform$63.00Medium
5/6/2019DA DavidsonBoost Price TargetNeutral$52.00High
5/3/2019Morgan StanleySet Price TargetHold$53.00Low
5/3/2019BTIG ResearchBoost Price TargetBuy ➝ Positive$62.00High
5/3/2019Northland SecuritiesReiterated RatingBuy$64.00High
4/29/2019Needham & Company LLCBoost Price TargetBuy ➝ Buy$50.00 ➝ $60.00Low
4/15/2019KeyCorpBoost Price TargetOverweight ➝ Overweight$50.00 ➝ $60.00Low
4/12/2019BarclaysBoost Price TargetOverweight$48.00 ➝ $61.00Low
4/3/2019Robert W. BairdInitiated CoverageOutperform ➝ Outperform$58.00High
4/3/2019Stifel NicolausBoost Price TargetBuy ➝ Buy$52.00 ➝ $58.00Low
3/26/2019MizuhoInitiated CoverageBuy ➝ Buy$59.00High
3/11/2019MacquarieUpgradeNeutral ➝ OutperformHigh
2/8/2019Morgan StanleySet Price TargetHold$42.00Medium
2/8/2019Needham & Company LLCReiterated RatingBuy ➝ Buy$42.00 ➝ $50.00High
2/8/2019DA DavidsonBoost Price TargetNeutral$40.00High
2/8/2019Monness Crespi & HardtReiterated RatingBuy ➝ Buy$41.00 ➝ $49.00High
1/29/2019Raymond JamesUpgradeOutperform ➝ Strong-Buy$39.00 ➝ $45.00Low
1/15/2019BTIG ResearchUpgradeNeutral ➝ Buy$42.00High
11/29/2018Berenberg BankInitiated CoverageBuy ➝ Buy$41.00Low
11/7/2018Morgan StanleySet Price TargetHold$35.00High
11/7/2018Monness Crespi & HardtBoost Price TargetBuy$38.00 ➝ $41.00High
10/2/2018Stifel NicolausBoost Price TargetBuy ➝ Buy$42.00 ➝ $44.00Low
9/21/2018Needham & Company LLCBoost Price TargetBuy ➝ Buy$37.00 ➝ $42.00Low
8/7/2018Monness Crespi & HardtBoost Price TargetBuy$35.00 ➝ $38.00High
8/7/2018KeyCorpBoost Price TargetOverweight ➝ Overweight$35.00 ➝ $38.00High
8/7/2018Stifel NicolausBoost Price TargetBuy ➝ Buy$36.00 ➝ $42.00High
8/7/2018Royal Bank of CanadaReiterated RatingBuy$40.00High
6/18/2018BTIG ResearchDowngradeBuy ➝ NeutralMedium
5/10/2018Rosenblatt SecuritiesReiterated RatingBuy$37.00Low
5/10/2018Needham & Company LLCBoost Price TargetBuy ➝ Buy$33.00 ➝ $37.00Low
5/10/2018BarclaysReiterated RatingBuy$36.00Low
5/9/2018Stifel NicolausBoost Price TargetBuy ➝ Buy$32.00 ➝ $36.00Medium
5/9/2018Morgan StanleyBoost Price TargetEqual Weight ➝ Equal Weight$23.00 ➝ $30.00Medium
5/9/2018KeyCorpBoost Price TargetOverweight ➝ Overweight$30.00 ➝ $35.00Medium
5/4/2018Monness Crespi & HardtBoost Price TargetBuy ➝ Buy$27.00 ➝ $33.00High
4/20/2018CowenReiterated RatingBuy$30.00Medium
4/13/2018BTIG ResearchInitiated CoverageBuy ➝ Buy$34.00High
4/10/2018DA DavidsonInitiated CoverageNeutral ➝ Neutral$28.00Low
2/28/2018Stifel NicolausInitiated CoverageBuy ➝ Buy$32.00High
2/13/2018Morgan StanleyBoost Price TargetEqual Weight ➝ Equal Weight$20.00 ➝ $23.00Low
2/13/2018Monness Crespi & HardtReiterated RatingBuy ➝ Buy$23.00 ➝ $27.00Low
2/12/2018Needham & Company LLCReiterated RatingBuy ➝ Buy$23.00 ➝ $30.00Low
1/30/2018KeyCorpReiterated RatingOverweight ➝ Overweight$25.00 ➝ $30.00Low
1/26/2018Royal Bank of CanadaReiterated RatingBuy$30.00Medium
1/24/2018Susquehanna BancsharesBoost Price TargetPositive ➝ Positive$22.00 ➝ $28.00Medium
1/24/2018Northland SecuritiesSet Price TargetBuy$28.00High
12/14/2017Rosenblatt SecuritiesReiterated RatingBuy$23.00High
11/8/2017Royal Bank of CanadaBoost Price TargetOutperform$22.00 ➝ $25.00N/A
10/23/2017Needham & Company LLCInitiated CoverageBuy ➝ Buy$23.00N/A
10/6/2017KeyCorpReiterated RatingBuy$25.00N/A
8/8/2017Susquehanna BancsharesUpgradeNeutral ➝ Positive$20.00High
8/8/2017UBS GroupUpgradeNeutral ➝ Positive$20.00High
7/14/2017Northland SecuritiesReiterated RatingBuy$23.00Low
6/7/2017Susquehanna BancsharesInitiated CoverageNeutral ➝ Neutral$20.00High
5/30/2017Monness Crespi & HardtInitiated CoverageBuy ➝ Buy$23.00High
5/10/2017Royal Bank of CanadaBoost Price TargetOutperform ➝ Outperform$19.00 ➝ $22.00Low
4/14/2017CowenReiterated RatingHold$11.50N/A
3/31/2017Royal Bank of CanadaReiterated RatingBuy$19.00Low
2/16/2017BarclaysReiterated RatingOverweight$16.00 ➝ $17.00N/A
2/10/2017BarclaysBoost Price TargetBuy$17.00N/A
(Data available from 1/18/2017 forward)

News Sentiment Rating

0.07 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/22/2021
  • 3 very positive mentions
  • 14 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Mentions as of
7/22/2021
  • 3 very positive mentions
  • 18 positive mentions
  • 4 negative mentions
  • 1 very negative mentions
Mentions as of
8/21/2021
  • 2 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/20/2021
  • 2 very positive mentions
  • 8 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/20/2021
  • 5 very positive mentions
  • 15 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
11/19/2021
  • 1 very positive mentions
  • 7 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Mentions as of
12/19/2021
  • 1 very positive mentions
  • 10 positive mentions
  • 4 negative mentions
  • 0 very negative mentions
Mentions as of
1/18/2022

Current Sentiment

  • 1 very positive mentions
  • 10 positive mentions
  • 4 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

Positive

Very Positive

Rapid7 logo
Rapid7, Inc. engages in the provision of cyber security analytics and automation services. Its products include Metasploit, Nexpose, AppSpider, tCell by Rapid7, as well as insight platforms such as InsightDR, InsightIVM, InsightAppSec, InsightConnect, and InsightOps. It also offers security and product consulting services. The company was founded by Alan P. Matthews, Tas Giakouminakis, and Chad Loder in July 2000 and is headquartered in Boston, MA.
Read More

Today's Range

Now: $96.45
Low: $94.32
High: $98.13

50 Day Range

MA: $119.05
Low: $96.45
High: $138.51

52 Week Range

Now: $96.45
Low: $72.02
High: $145.00

Volume

446,405 shs

Average Volume

562,070 shs

Market Capitalization

$5.45 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.34

Frequently Asked Questions

What sell-side analysts currently cover shares of Rapid7?

The following equities research analysts have issued research reports on Rapid7 in the last twelve months: Barclays PLC, FBN Securities, KeyCorp, Mizuho, Monness Crespi & Hardt, Morgan Stanley, Needham & Company LLC, Piper Sandler, Raymond James, Robert W. Baird, Royal Bank of Canada, Stifel Nicolaus, The Goldman Sachs Group, Inc., TheStreet, Truist, Truist Securities, and Zacks Investment Research.
View the latest analyst ratings for RPD.

What is the current price target for Rapid7?

15 Wall Street analysts have set twelve-month price targets for Rapid7 in the last year. Their average twelve-month price target is $138.53, suggesting a possible upside of 43.6%. KeyCorp has the highest price target set, predicting RPD will reach $162.00 in the next twelve months. Monness Crespi & Hardt has the lowest price target set, forecasting a price of $100.00 for Rapid7 in the next year.
View the latest price targets for RPD.

What is the current consensus analyst rating for Rapid7?

Rapid7 currently has 1 hold rating and 14 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe RPD will outperform the market and that investors should add to their positions of Rapid7.
View the latest ratings for RPD.

How do I contact Rapid7's investor relations team?

Rapid7's physical mailing address is 120 Causeway Street, Boston MA, 02114. The technology company's listed phone number is (617) 247-1717 and its investor relations email address is [email protected] The official website for Rapid7 is www.rapid7.com.